Company Profiles

driven by the PitchBook Platform

Avillion

Description

Operator of a drug development company focusing on the development of late stage pharmaceutical products. The company offers pharmaceutical and biotechnology companies a option to partner and deliver effective drugs to patients.

2012

Founded

PRIVATE

Status

Corporate

Latest Deal Type

3

Investors

Description

Operator of a drug development company focusing on the development of late stage pharmaceutical products. The company offers pharmaceutical and biotechnology companies a option to partner and deliver effective drugs to patients.

Website:

www.avillionllp.com

Ownership Status

Privately held (backing)

Financing Status

Venture Capital-Backed

Primary Industry

Biotechnology

Other Industries

Pharmaceuticals
Drug Discovery

Primary Office

111 Buckingham Palace Road Westminister London SW1W 0SREngland +44 (0)20 3764 9530
    Request a free trial to the PitchBook Platform
    You're viewing a free company profile from the PitchBook Platform. To explore Avillion's full profile, request a free trial.

    Avillion Valuation and Funding

    Request access
    Deal TypeDateAmountRaised to DatePost-ValStatusStage

    Avillion Investors (3)

    Request access
    Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
    Seat
    Contact
    Info
    Abingworth ManagementVenture CapitalMinority000 0000000 0000
    Clarus VenturesVenture CapitalMinority000 0000000 0000
    Royalty PharmaPE-Backed CompanyMinority000 0000000 0000
    Abingworth Management Venture Capital
    Clarus Ventures Venture Capital
    Royalty Pharma PE-Backed Company

    Avillion Executive Team (5)

    NameTitleBoard
    Seat
    Contact
    Info
    Allison Jeynes-EllisChief Executive Officer
    John BradshawChief Financial Officer
    Jarrod LongcorChief Business Officer
    Anna DanilewiczHead of Clinical Operations
    Mark Weinberg MDChief Medical Officer
    Allison Jeynes-Ellis Chief Executive Officer
    John Bradshaw Chief Financial Officer
    Jarrod Longcor Chief Business Officer
    Anna Danilewicz Head of Clinical Operations
    Mark Weinberg MD Chief Medical Officer

    Avillion Board Members (7)

    NameRepresentingRoleSinceContact
    Info
    Emmett Cunningham Jr.Clarus VenturesPartner000 0000
    Genghis Lloyd-Harris Ph.DAbingworth ManagementPartner000 0000
    Jim Reddoch Ph.DRoyalty PharmaExecutive Vice President & Head of Research & Investments000 0000
    Kurt WheelerClarus VenturesManaging Director000 0000
    Robert LiptakClarus VenturesManaging Director000 0000
    Emmett Cunningham Jr. Partner Clarus Ventures
    Genghis Lloyd-Harris Ph.D Partner Abingworth Management
    Jim Reddoch Ph.D Executive Vice President & Head of Research & Investments Royalty Pharma
    Kurt Wheeler Managing Director Clarus Ventures
    Robert Liptak Managing Director Clarus Ventures
    Request full access to PitchBook